Skip to main content

Table 2 Adjusted hazard ratios for other site-specific cancers associated with dairy intakea

From: Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people

Types

Never/rarely intake

Monthly intake

Regular intake

P trend

FDR-corrected P trendb

HR (95% CI) per 50 g/day of usual dairy intake

No. of cases

HR (95% CI)

No. of cases

HR (95% CI)

No. of cases

HR (95% CI)

Oral cavity

573

1.00 (0.89–1.12)

98

0.97 (0.80–1.18)

156

0.98 (0.82–1.18)

0.83

0.90

1.00 (0.83–1.20)

Oesophagus

1953

1.00 (0.95–1.06)

209

0.89 (0.78–1.02)

306

1.07 (0.94–1.21)

0.73

0.90

1.03 (0.92–1.15)

Stomach

2495

1.00 (0.95–1.05)

338

1.06 (0.95–1.17)

744

1.08 (1.00–1.18)

0.10

0.34

1.07 (0.99–1.16)

Colon-rectum

2066

1.00 (0.94–1.06)

385

1.10 (1.00–1.21)

899

1.09 (1.01–1.18)

0.06

0.26

1.08 (1.00–1.17)

Pancreas

605

1.00 (0.89–1.12)

74

0.96 (0.76–1.20)

207

1.11 (0.95–1.31)

0.33

0.70

1.09 (0.93–1.29)

Larynx

142

1.00 (0.81–1.24)

19

0.79 (0.05–1.23)

48

1.08 (0.77–1.52)

0.86

0.90

1.05 (0.74–1.47)

Lung

4185

1.00 (0.96–1.04)

667

1.02 (0.94–1.10)

1430

1.03 (0.96–1.09)

0.48

0.82

1.03 (0.96–1.09)

Kidney

258

1.00 (0.85–1.18)

45

1.01 (0.76–1.35)

147

1.21 (0.99–1.48)

0.15

0.43

1.18 (0.96–1.46)

Bladder

368

1.00 (0.87–1.14)

66

1.04 (0.82–1.32)

134

0.84 (0.69–1.02)

0.19

0.46

0.91 (0.75–1.11)

Leukaemia

453

1.00 (0.88–1.13)

76

1.12 (0.89–1.39)

133

0.96 (0.79–1.18)

0.90

0.90

0.92 (0.75–1.13)

Prostate

278

1.00 (0.85–1.17)

40

0.93 (0.69–1.27)

107

0.95 (0.76–1.19)

0.70

0.90

0.97 (0.77–1.22)

Cervix

847

1.00 (0.91–1.09)

155

0.97 (0.83–1.14)

257

1.09 (0.93–1.26)

0.44

0.82

1.07 (0.92–1.25)

Endometrium

292

1.00 (0.85–1.17)

53

1.07 (0.82–1.40)

123

0.94 (0.76–1.16)

0.72

0.90

1.00 (0.80–1.25)

Ovary

324

1.00 (0.86–1.16)

54

0.91 (0.70–1.19)

129

0.98 (0.79–1.20)

0.79

0.90

1.03 (0.83–1.29)

  1. CI confidence interval, FDR false discovery rate, HR hazard ratio
  2. aCox regression analyses were performed among 510,146 participants with no prior self-reported history of cancer at baseline. Analyses were stratified by age-at-risk (continuous variable), sex (dichotomous variable) and individual regions (ten regions) and were adjusted for education (four categories), income (four categories), smoking (four categories), alcohol consumption (four categories), total physical activity (continuous variable), family history of cancer (dichotomous variable), fresh fruit consumption (five categories), soy consumption (three categories) and body mass index (continuous variable)
  3. bSignificance was assessed at a 5% FDR
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us